Tumor invasion and metastasis mechanisms commonly involve urokinase-type plasminogen activator (uPA) and its receptor (uPAR), which activate matrix metalloproteinases (MMPs) and degrade the extracellular matrix, facilitating cancer cell invasion [17,39]. Here, PLAU is linked to cancer.